Publications 2024

Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, Larstorp ACK, Søraas CL, Rossebø AB, Rösner A, Grytaas MA, Gerdts E (2024)
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
High Blood Press Cardiovasc Prev, 31 (2), 157-166
DOI 10.1007/s40292-024-00632-6, PubMed 38530572

Bahlmann E, Gerdts E, Einarsen E, Midtbø H, Pedersen ER, Rossebø A, Willems S, Cramariuc D (2024)
Impact of sex-specific thresholds for low flow in assessment of prognosis in concordantly and discordantly graded aortic valve stenosis
Eur Heart J Cardiovasc Imaging (in press)
DOI 10.1093/ehjci/jeae272, PubMed 39467305

Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Nienaber CA, Ray SG, Rossebø AB, Wachtell K, Dominguez H, Valeur N, Carstensen HG, Nielsen OW (2024)
Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwae086, PubMed 38416125

Publications 2023

Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Wachtell K, Nielsen OW (2023)
Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial
EClinicalMedicine, 58, 101875
DOI 10.1016/j.eclinm.2023.101875, PubMed 36915288

Publications 2022

Bahlmann E, Einarsen E, Cramariuc D, Pedersen ER, Rossebø AB, Midtbø H, Willems S, Gerdts E (2022)
Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area
Open Heart, 9 (2)
DOI 10.1136/openhrt-2022-002159, PubMed 36428084

Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Willenheimer R, Wachtell K, Nielsen OW (2022)
Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial
JAMA Cardiol, 7 (4), 435-444
DOI 10.1001/jamacardio.2021.5916, PubMed 35171199

Publications 2021

Bahlmann E, Einarsen E, Cramariuc D, Midtbø H, Mancusi C, Rossebø A, Willems S, Gerdts E (2021)
Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001720, PubMed 34426527

Publications 2020

Cramariuc D, Bahlmann E, Egstrup K, Rossebø AB, Ray S, Kesäniemi YA, Nienaber CA, Gerdts E (2020)
Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis
Echocardiography, 38 (1), 31-38
DOI 10.1111/echo.14916, PubMed 33146452

Minners J, Rossebo A, Chambers JB, Gohlke-Baerwolf C, Neumann FJ, Wachtell K, Jander N (2020)
Sudden cardiac death in asymptomatic patients with aortic stenosis
Heart, 106 (21), 1646-1650
DOI 10.1136/heartjnl-2019-316493, PubMed 32737125

Publications 2019

Gerdts E, Saeed S, Midtbø H, Rossebø A, Chambers JB, Einarsen E, Bahlmann E, Devereux R (2019)
Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis
Heart, 105 (21), 1629-1633
DOI 10.1136/heartjnl-2018-314462, PubMed 31154431

Publications 2017

Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K (2017)
Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events
J Am Heart Assoc, 6 (12)
DOI 10.1161/JAHA.117.006709, PubMed 29180457

Lønnebakken MT, De Simone G, Saeed S, Boman K, Rossebø AB, Bahlmann E, Gohlke-Bärwolf C, Gerdts E (2017)
Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis
Heart, 103 (18), 1443-1448
DOI 10.1136/heartjnl-2016-310917, PubMed 28455295

Publications 2015

Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K (2015)
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
Am J Cardiol, 116 (12), 1840-4
DOI 10.1016/j.amjcard.2015.09.026, PubMed 26602073

Blyme A, Asferg C, Nielsen OW, Sehestedt T, Kesäniemi YA, Gohlke-Bärwolf C, Boman K, Willenheimer R, Ray S, Nienaber CA, Rossebø A, Wachtell K, Olsen MH (2015)
High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy
Open Heart, 2 (1), e000152
DOI 10.1136/openhrt-2014-000152, PubMed 25685360

Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB (2015)
Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis
Circ Cardiovasc Imaging, 8 (11), e003644; discussion e003644
DOI 10.1161/CIRCIMAGING.115.003644, PubMed 26489804

Publications 2014

Bang CN, Greve AM, Køber L, Rossebø AB, Ray S, Boman K, Nienaber CA, Devereux RB, Wachtell K (2014)
Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis
Int J Cardiol, 175 (3), 492-8
DOI 10.1016/j.ijcard.2014.06.013, PubMed 25012498

Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K (2014)
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study
Int J Cardiol, 180, 122-8
DOI 10.1016/j.ijcard.2014.11.181, PubMed 25438232

Greve AM, Dalsgaard M, Bang CN, Egstrup K, Ray S, Boman K, Rossebø AB, Gohlke-Baerwolf C, Devereux RB, Køber L, Wachtell K (2014)
Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Stroke, 45 (7), 1939-46
DOI 10.1161/STROKEAHA.114.005296, PubMed 24903982

Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K (2014)
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
Am J Cardiol, 114 (5), 751-6
DOI 10.1016/j.amjcard.2014.06.006, PubMed 25048345

Jander N, Hochholzer W, Kaufmann BA, Bahlmann E, Gerdts E, Boman K, Chambers JB, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Wachtell K, Gohlke-Bärwolf C, Neumann FJ, Minners J (2014)
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF
Heart, 100 (24), 1946-53
DOI 10.1136/heartjnl-2014-305763, PubMed 25217488

Publications 2013

Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K (2013)
Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study
Int J Cardiol, 168 (3), 2322-7
DOI 10.1016/j.ijcard.2013.01.060, PubMed 23416018

Jander N, Gohlke-Bärwolf C, Bahlmann E, Gerdts E, Boman K, Chambers JB, Egstrup K, Nienaber CA, Pedersen TR, Ray S, Rossebø AB, Willenheimer R, Kienzle RP, Wachtell K, Neumann FJ, Minners J (2013)
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis
Heart, 100 (1), 28-33
DOI 10.1136/heartjnl-2013-304443, PubMed 23969478

Publications 2012

Bang CN, Greve AM, Boman K, Egstrup K, Gohlke-Baerwolf C, Køber L, Nienaber CA, Ray S, Rossebø AB, Wachtell K (2012)
Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study
Am Heart J, 163 (4), 690-6
DOI 10.1016/j.ahj.2012.01.026, PubMed 22520536

Cioffi G, Cramariuc D, Dalsgaard M, Davidsen ES, Egstrup K, Rossebo AB, de Simone G, Gerdts E (2012)
Proper Use of Left Atrial Ejection Force as a Measure of Left Atrial Mechanical Function Reply
Echocardiography-J. Cardiovasc. Ultrasound Allied Tech., 29 (7), 881-882

Cioffi G, Cramariuc D, Dalsgaard M, Davidsen ES, Egstrup K, Rossebø AB, de Simone G, Gerdts E (2012)
Left atrial systolic force and outcome in asymptomatic mild to moderate aortic stenosis
Echocardiography, 29 (9), 1038-44
DOI 10.1111/j.1540-8175.2012.01744.x, PubMed 22676207

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Devereux RB, Køber L, Ray S, Willenheimer R, Wachtell K (2012)
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
J Am Coll Cardiol, 59 (13), 1142-9
DOI 10.1016/j.jacc.2011.12.020, PubMed 22440214

Rieck ÅE, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E (2012)
Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events
Hypertension, 60 (1), 90-7
DOI 10.1161/HYPERTENSIONAHA.112.194878, PubMed 22647889

Rossebø AB (2012)
Is aortic bioprosthesis degeneration influenced by metabolic factors?
Cardiology, 121 (4), 274-6
DOI 10.1159/000338565, PubMed 22626909

Publications 2011

Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K (2011)
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Circulation, 125 (2), 346-53
DOI 10.1161/CIRCULATIONAHA.111.049759, PubMed 22147903

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Hammer-Hansen S, Køber L, Willenheimer R, Wachtell K (2011)
Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)
Am J Cardiol, 108 (4), 541-7
DOI 10.1016/j.amjcard.2011.03.084, PubMed 21624542

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K (2011)
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Int J Cardiol, 166 (1), 72-6
DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417

Holme I, Pedersen TR, Boman K, Egstrup K, Gerdts E, Kesäniemi YA, Malbecq W, Ray S, Rossebø AB, Wachtell K, Willenheimer R, Gohlke-Bärwolf C (2011)
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis
Heart, 98 (5), 377-83
DOI 10.1136/heartjnl-2011-300475, PubMed 22155702

Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C (2011)
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction
Circulation, 123 (8), 887-95
DOI 10.1161/CIRCULATIONAHA.110.983510, PubMed 21321152

Jander N, Minners J, Neumann FJ, Gohlke-Barwolf C, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Skjaerpe T, Willenheimer R, Wachtell K (2011)
Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction"
Circulation, 124 (13), E362-E363
DOI 10.1161/CIRCULATIONAHA.111.045203

Publications 2010

Gerdts E, Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber C, Ray S, Skjærpe T, Wachtell K, Willenheimer R (2010)
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)
Am J Cardiol, 106 (11), 1634-9
DOI 10.1016/j.amjcard.2010.07.042, PubMed 21094366

Holme I, Boman K, Brudi P, Egstrup K, Gohlke-Baerwolf C, Kesäniemi YA, Malbecq W, Rossebø AB, Wachtell K, Willenheimer R, Pedersen TR (2010)
Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial
Am J Cardiol, 105 (12), 1802-8
DOI 10.1016/j.amjcard.2010.01.363, PubMed 20538134

Lund BP, Gohlke-Bärwolf C, Cramariuc D, Rossebø AB, Rieck AE, Gerdts E (2010)
Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy)
Am J Cardiol, 105 (10), 1456-60
DOI 10.1016/j.amjcard.2009.12.069, PubMed 20451694

Rieck AE, Cramariuc D, Staal EM, Rossebø AB, Wachtell K, Gerdts E (2010)
Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy)
J Hypertens, 28 (2), 377-83
DOI 10.1097/HJH.0b013e328332fa44, PubMed 19844185

Publications 2009

Rossebo AB, Pedersen TR, Kesaniemi YA (2009)
Calcific Aortic Stenosis Reply
N. Engl. J. Med., 360 (1), 85-86

Rossebø AB, Gerdts E, Pedersen TR, SEAS Study Steering Committee (2009)
Aortic valve stenosis
Lancet, 373 (9680), 2022-3; author reply 2023
DOI 10.1016/S0140-6736(09)61104-1, PubMed 19524771

Publications 2008

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R, SEAS Investigators (2008)
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
N Engl J Med, 359 (13), 1343-56
DOI 10.1056/NEJMoa0804602, PubMed 18765433

Steine K, Rossebø AB, Stugaard M, Pedersen TR (2008)
Left ventricular systolic and diastolic function in asymptomatic patients with moderate aortic stenosis
Am J Cardiol, 102 (7), 897-901
DOI 10.1016/j.amjcard.2008.07.001, PubMed 18805118

Publications 2007

Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebø AB, Gerdts E (2007)
Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy)
Am J Cardiol, 101 (4), 510-5
DOI 10.1016/j.amjcard.2007.09.100, PubMed 18312768

Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R (2007)
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study
Am J Cardiol, 99 (7), 970-3
DOI 10.1016/j.amjcard.2006.10.064, PubMed 17398194

Publications 2004

Rossebø AB, Pedersen TR (2004)
Hyperlipidaemia and aortic valve disease
Curr Opin Lipidol, 15 (4), 447-51
DOI 10.1097/01.mol.0000137229.00020.fe, PubMed 15243218

Rossebø AB, Pedersen TR (2004)
Hyperlipidaemia and aortic valve disease
In Current opinion in lipidology, Current Science, London, 15(2204)4, S. 447-451
BIBSYS 051932180